Banco Bilbao Vizcaya Argentaria Colombia SA:企業の戦略・SWOT・財務分析

◆英語タイトル:Banco Bilbao Vizcaya Argentaria Colombia SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3885
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:コロンビア
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Banco Bilbao Vizcaya Argentaria Colombia SA – Strategy, SWOT and Corporate Finance Report
Summary

Banco Bilbao Vizcaya Argentaria Colombia SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Banco Bilbao Vizcaya Argentaria Colombia SA (BBVA Colombia), a subsidiary of Banco Bilbao Vizcaya Argentaria, SA, is a provider of banking products and related financial solutions. Its offerings comprise of card products, commercial lines of credit, current and savings accounts, deposit schemes, life insurance products, financial planning and investment solutions, brokerage, trade services, money market services, and treasury services. Additionally, BBVA Colombia also offers foreign trade services, asset management, cash management, electronic banking, investment banking, payroll, and remittance services as part of its financial services portfolio. The bank operates through its wide network of offices across Colombia. BBVA Colombia is headquartered in Bogota, Colombia.

Scope

- Detailed information on Banco Bilbao Vizcaya Argentaria Colombia SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Banco Bilbao Vizcaya Argentaria Colombia SA in the form of a SWOT analysis
- An in-depth view of the business model of Banco Bilbao Vizcaya Argentaria Colombia SA including a breakdown and examination of key business segments
- Intelligence on Banco Bilbao Vizcaya Argentaria Colombia SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Banco Bilbao Vizcaya Argentaria Colombia SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Banco Bilbao Vizcaya Argentaria Colombia SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Banco Bilbao Vizcaya Argentaria Colombia SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Banco Bilbao Vizcaya Argentaria Colombia SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Banco Bilbao Vizcaya Argentaria Colombia SA: Company Overview
Banco Bilbao Vizcaya Argentaria Colombia SA: Overview and Key Facts
Banco Bilbao Vizcaya Argentaria Colombia SA: Overview
Banco Bilbao Vizcaya Argentaria Colombia SA: Key Facts
Banco Bilbao Vizcaya Argentaria Colombia SA: Key Employees
Banco Bilbao Vizcaya Argentaria Colombia SA: Key Employee Biographies
Banco Bilbao Vizcaya Argentaria Colombia SA: Major Products and Services
Banco Bilbao Vizcaya Argentaria Colombia SA: Company History
Banco Bilbao Vizcaya Argentaria Colombia SA: Locations and Subsidiaries
Banco Bilbao Vizcaya Argentaria Colombia SA: Key Competitors
Banco Bilbao Vizcaya Argentaria Colombia SA: Company Analysis
Banco Bilbao Vizcaya Argentaria Colombia SA: Business Description
Banco Bilbao Vizcaya Argentaria Colombia SA: SWOT Analysis
Banco Bilbao Vizcaya Argentaria Colombia SA: SWOT Overview
Banco Bilbao Vizcaya Argentaria Colombia SA: Strengths
Banco Bilbao Vizcaya Argentaria Colombia SA: Weaknesses
Banco Bilbao Vizcaya Argentaria Colombia SA: Opportunities
Banco Bilbao Vizcaya Argentaria Colombia SA: Threats
Banco Bilbao Vizcaya Argentaria Colombia SA: Corporate Financial Deals Activity
Banco Bilbao Vizcaya Argentaria Colombia SA: Financial Deals Overview
Banco Bilbao Vizcaya Argentaria Colombia SA: Top Deals 2015 – 2019YTD*
Banco Bilbao Vizcaya Argentaria Colombia SA: Mergers and Acquisitions
Banco Bilbao Vizcaya Argentaria Colombia SA: Capital Raising
Banco Bilbao Vizcaya Argentaria Colombia SA: Recent Developments
Banco Bilbao Vizcaya Argentaria Colombia SA: News and Events Summary
Banco Bilbao Vizcaya Argentaria Colombia SA: Corporate Governance
Banco Bilbao Vizcaya Argentaria Colombia SA: Financial Deals
Banco Bilbao Vizcaya Argentaria Colombia SA: Red Flags/DistressSignals
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Banco Bilbao Vizcaya Argentaria Colombia SA: Key Facts
Table 2: Banco Bilbao Vizcaya Argentaria Colombia SA: Key Employees
Table 3: Banco Bilbao Vizcaya Argentaria Colombia SA: Company History
Table 4: Banco Bilbao Vizcaya Argentaria Colombia SA: Locations and Subsidiaries
Table 5: Banco Bilbao Vizcaya Argentaria Colombia SA: Key Competitors
Table 6: Banco Bilbao Vizcaya Argentaria Colombia SA: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Banco Bilbao Vizcaya Argentaria Colombia SA: Top Deals 2015 - 2019YTD*
Table 8: Banco Bilbao Vizcaya Argentaria Colombia SA: M&A Volume and Value Trend (2015 - YTD*2019)
Table 9: Banco Bilbao Vizcaya Argentaria Colombia SA: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 10: Banco Bilbao Vizcaya Argentaria Colombia SA: Capital Raising by Deal Type (2015 - YTD*2019)
Table 11: Banco Bilbao Vizcaya Argentaria Colombia SA: News and Events Summary
Table 12: Banco Bilbao Vizcaya Argentaria Colombia SA: Corporate Governance
Table 13: Banco Bilbao Vizcaya Argentaria Colombia SA: Financial Deals
Table 14: Banco Bilbao Vizcaya Argentaria Colombia SA: Red Flags/DistressSignals

★海外企業調査レポート[Banco Bilbao Vizcaya Argentaria Colombia SA:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asure Software, Inc. (ASUR):企業の財務・戦略的SWOT分析
    Asure Software, Inc. (ASUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Avedro Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-lin …
  • Thermax Ltd (THERMAX):企業の財務・戦略的SWOT分析
    Thermax Ltd (THERMAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bank of England:企業の戦略・SWOT・財務分析
    Bank of England - Strategy, SWOT and Corporate Finance Report Summary Bank of England - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Aeterna Zentaris Inc (AEZS):医療機器:M&Aディール及び事業提携情報
    Summary Aeterna Zentaris Inc (Aeterna Zentaris) is a specialty biopharmaceutical company that focuses on the development and commercialization of novel pharmaceutical therapies for the treatment of endocrine disorders. The company’s lead product, macimorelin, a ghrelin receptor agonist and orally-ac …
  • Revera Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Revera Inc (Revera), formerly Retirement Residences Real Estate Investment Trust, is a healthcare service provider that offers assisted living, independent living, seniors’ apartments,memory care and long term care services. The center provides person-centered care, quality care, clinical pr …
  • Arcelik A.S. (ARCLK):企業の財務・戦略的SWOT分析
    Arcelik A.S. (ARCLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Arla Foods Ingredients Group P/S:戦略・SWOT・企業財務分析
    Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report Summary Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Bloomberg LP:企業の戦略的SWOT分析
    Bloomberg LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Facebook, Inc.:企業のM&A・事業提携・投資動向
    Facebook, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Facebook, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Adamas Pharmaceuticals Inc (ADMS):製薬・医療:M&Aディール及び事業提携情報
    Summary Adamas Pharmaceuticals Inc (Adamas Pharmaceuticals) is a pharmaceutical company that develops and commercializes therapeutics for chronic disorders of the central nervous system. The company's Gocovri, formerly ADS-5102, is an amantadine extended-release (XR) formulation for the treatment fo …
  • Telos Corporation:企業の戦略・SWOT・財務情報
    Telos Corporation - Strategy, SWOT and Corporate Finance Report Summary Telos Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Kering SA:企業の戦略・SWOT・財務情報
    Kering SA - Strategy, SWOT and Corporate Finance Report Summary Kering SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Kobayashi Pharmaceutical Co Ltd (4967)-製薬・医療分野:企業M&A・提携分析
    Summary Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, and body w …
  • PositiveID Corp (PSID):医療機器:M&Aディール及び事業提携情報
    Summary PositiveID Corp (PositiveID), formerly VeriChip Corp is a life sciences tools and diagnostics company that develops biological detection and molecular diagnostic systems. The company develops microfluidic systems for automated preparation and performance of biological assays. Its products in …
  • Vernalis Plc (VER)-製薬・医療分野:企業M&A・提携分析
    Summary Vernalis plc (Vernalis) is a pharmaceutical company, which focuses at developing novel pharmaceuticals for the treatment of several diseases. The product portfolio of the company comprises frovatriptan for the acute treatment of migraine; Tuzistra XR, which targets the US prescription cough …
  • Dohler GmbH:企業の戦略・SWOT・財務分析
    Dohler GmbH - Strategy, SWOT and Corporate Finance Report Summary Dohler GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Bangkok Bank Public Co Ltd:企業のM&A・事業提携・投資動向
    Bangkok Bank Public Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bangkok Bank Public Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • KPC Pharmaceuticals Inc (600422)-製薬・医療分野:企業M&A・提携分析
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and botanical drugs. It also offers drugs such as xue …
  • Exactech Inc (EXAC):企業の財務・戦略的SWOT分析
    Summary Exactech Inc (Exactech) is a medical device company that offers orthopedic implant devices and related surgical instruments. The company’s products comprise hip implants, shoulder implants, knee implants, extremity implants, biologics and spine, and other products. It also provides biologic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆